Cardiovascular risk profile in high risk primary care patients not treated with lipid-lowering treatment

被引：0
|
作者：
Dallongeville, J. [1 ]
Bruckert, E. [2 ]
Ferrieres, J. [3 ]
Delaage, P. H. [4 ]
Thomas-Delecourt, F. [4 ]
Bonnelye, G. [5 ]
Kownator, S.
机构：
[1] Inst Pasteur, INSERM, U744, F-59019 Lille, France
[2] Hosp Pitie Salpetriere, AP HP, Div Endocrinol & Metab, Paris, France
[3] Hop Rangueil, Univ Hosp Toulouse, Dept Cardiol B, Toulouse, France
[4] AstraZeneca France, Rueil Malmaison, France
[5] Kantar Hlth, Montrouge, France
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [41] Comparison of Lipid-Lowering Treatment in Patients with Diabetes and/or Cardiovascular Disease
    Cohen, Sarah S.
    Chamberlain, Alanna M.
    Killian, Jill M.
    Monda, Keri L.
    Weston, Susan A.
    Okerson, Ted
    [J]. DIABETES, 2017, 66 : LB57 - LB57
  • [42] Are high coronary risk patients missing out on lipid-lowering drugs in Australia?
    Simons, Leon A.
    Chung, Eric
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2014, 201 (04) : 213 - 216
  • [43] Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk
    Nieuwkerk, Pythia T.
    Nierman, Melchior C.
    Vissers, Maud N.
    Locadia, Mirjam
    Greggers-Peusch, Philip
    Knape, Leon P. M.
    Kastelein, John J. P.
    Sprangers, Mirjam A. G.
    de Haes, Hanneke C.
    Stroes, Erik S. G.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (05): : 666 - 672
  • [44] Lipid-lowering drugs and risk for cancer
    Pedersen, Terje R.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (05) : 350 - 357
  • [45] Lipid-lowering medication and risk of cancer
    Olsen, JH
    Johansen, C
    Sorensen, HT
    McLaughlin, JK
    Mellemkjær, L
    Steffensen, FH
    Fraumeni, JF
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (02) : 167 - 169
  • [46] Simulation of lipid-lowering therapy (LLT) intensification in very high-risk patients with atherosclerotic cardiovascular disease
    Gu, Jing
    Sanchez, Robert J.
    Chauhan, Ankita
    Fazio, Sergio
    Rosenson, Robert S.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (06) : 901 - 905
  • [47] Lipid lowering goals in high risk and very high cardiovascular risk patients:: a reasonable challenge?
    Gomez-Belda, A.
    Rodilla, E.
    Gonzalez, C.
    Costa, J. A.
    Serra, B.
    Pascual, J. M.
    [J]. REVISTA CLINICA ESPANOLA, 2006, 206 (09): : 417 - 421
  • [48] Clinical Significance of Mild Lipid-Lowering by Statins for Prevention of Cardiovascular Disease in Japanese High-Risk Patients
    Miyazaki, Tetsuro
    Daida, Hiroyuki
    [J]. CIRCULATION JOURNAL, 2010, 74 (04) : 630 - 631
  • [49] PATIENTS' AND HEALTHCARE PROFESSIONALS' PREFERENCES REGARDING LIPID-LOWERING THERAPIES FOR PATIENTS WITH VERY HIGH CARDIOVASCULAR RISK AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Garcia, Parrondo F. J.
    Olmo, Fernandez M. R.
    Hermida, Alvarez A. B.
    Castellanos, M.
    Gomez, Cerezo J.
    Guaita, Igual M. J.
    Chaparro, Jansen S. J.
    Rebollar, Obaya J. C.
    Mitjana, Martin L.
    Cosin-Sales, J.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S448 - S448
  • [50] Lipid-lowering agents and risk of melanoma
    Kirsner, RS
    Ramirez, CC
    Federman, DG
    Ma, FC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (02) : 333 - 333
12345